ANZ being Sued by Australian Watchdog ASIC for Withholding The Sensitive Information

Australia Securities and Investments Commission has initiated civil penalty proceedings against Australia and New Zealand Banking Group Limited (ASX: ANZ) alleging that the bank has failed to comply with its continuous disclosure obligations. The issue dates to 2015 and is related to an underwritten institutional placement in August 2015.

ANZ has already disclosed in June that it is under an active investigation conducted by ASIC wherein the Australian watchdog launched a criminal cartel case against the bank. According to ASIC, ANZ was bound to advise the market that the joint lead managers i.e. Deutsche Bank, Citi and JP Morgan held up 25.5 Mn shares of the placement. ANZ would defend the allegation stating that the total shares in question are below 1% of the issue at the time and were taken up by the managers because the boon suggested that placement was covered at 103%. The beleaguered Bank further stated that it had no knowledge of the norms wherein the listed company needs to disclose the shares taken up by the underwriters in an equity placement. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

ANZ chief risk officer Kevin Corbally stated that the disclosures made by ANZ are in tandem with the ASX disclosure obligations along with market practices. Therefore, ANZ would defend the matter and does not have anything more to say at present. The criminal cartel law suggests that an individual, if found guilty can face up to 10 years imprisonment or fines up to $420,000. Companies on the other hand would have to part ways with 10% of annual turnover, or thrice the profit made by the action.

ANZ was trading at $28.15, up 0.32% as on 14 September 2018 (AEST: 4:50 p.m.).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report